This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2026.
Company Filing History:
1 out of 5,383 
1 out of 28 Years Active: 2026
Title: Saverio Minervini: Innovator in Biofilm Inhibition
Introduction
Saverio Minervini is a notable inventor based in Saarbruecken, Germany. He has made significant contributions to the field of biofilm research, particularly through his innovative patent related to bivalent LECA inhibitors. His work focuses on addressing the challenges posed by biofilm formation in various infections.
Latest Patents
Saverio Minervini holds a patent for bivalent LECA inhibitors targeting biofilm formation. The present invention relates to divalent compounds that bind to LecA, which are useful in blocking biofilm formation. The invention also encompasses pharmaceutical compositions that include these compounds, as well as therapeutic methods and uses for treating infections in subjects. Additionally, it relates to imaging infections, such as biofilms, by utilizing these divalent compounds.
Career Highlights
Throughout his career, Saverio Minervini has worked with esteemed organizations, including Helmholtz-Zentrum für Infektionsforschung GmbH and Centre National de la Recherche Scientifique. His experience in these institutions has contributed to his expertise in the field of infection research and biofilm inhibition.
Collaborations
Saverio has collaborated with notable colleagues, including Alexander Titz and Eva Záhorská. These partnerships have further enhanced his research and development efforts in combating biofilm-related infections.
Conclusion
Saverio Minervini's innovative work in developing bivalent LECA inhibitors represents a significant advancement in the fight against biofilm formation in infections. His contributions to the field are invaluable and highlight the importance of continued research in this area.